JHS Svendgaard Laboratories profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| −1.1% | −1.1% | −11.5% | −2.4% | −8.6% | ||
| −0.9% | −0.9% | −9.9% | −1.9% | −7.3% | ||
| −2.7% | −2.7% | −6.8% | −3.9% | −8.3% | ||
| −1.6% | −2.2% | −7.0% | −4.4% | −9.0% | ||
Margins | ||||||
| 2.8% | 2.6% | −4.4% | −1.3% | −9.5% | ||
| −4.8% | −4.8% | −13.0% | −10.3% | −17.2% | ||
| — | 73.0% | −22.1% | −36.5% | — | ||
| −2.6% | −2.3% | −13.6% | −4.8% | −22.7% | ||
| −1.7% | −1.9% | −21.4% | −5.7% | −17.4% | ||
| — | — | −21.5% | −5.7% | −16.1% | ||
| −15.2% | −15.2% | −16.2% | −46.3% | 18.5% | ||
Additional | ||||||
| 33.9% | 16.1% | −57.5% | −18.4% | 23.2% | ||
| −1.1% | −1.1% | −11.5% | −2.4% | −8.6% | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.